Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd. (JPX: 2395) is trading at ¥1,352.00, about ₹823 at today's JPY/INR rate, as of 25 Sep 2026, 2:30 AM ET, up 1.50% today. Indian residents can buy Shin Nippon Biomedical Laboratories from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
¥1,332.00
Today's high
¥1,360.00
52 week low
¥1,067.00
52 week high
¥2,005.00
2395 opened at ¥1,332.00, closed previously at ¥1,332.00, and has traded between ¥1,067.00 and ¥2,005.00 over the past 52 weeks.
About
Shin Nippon Biomedical Laboratories, Ltd. operates as a global contract research organization (CRO), delivering comprehensive drug discovery and development services both in Japan and internationally. Its preclinical offerings encompass a wide array of laboratory services, including regulatory-compliant good laboratory practice (GLP) inspections. These studies cover general and specialized toxicity assessments, detailed pathological examinations, pharmacokinetic (PK) and pharmacodynamic (PD) analysis for biopharmaceuticals, immunotoxicity testing, and antibody production. The company also conducts investigations into reproductive and developmental toxicity, pharmacological mechanisms, and efficacy, alongside providing various imaging services. Furthermore, the organization specializes in developing and validating analytical methodologies, analyzing biological specimens, and determining pharmacokinetic parameters. It also conducts studies on absorption, distribution, metabolism, and excretion (ADME), often utilizing radioisotope-labeled compounds. Beyond preclinical and analytical work, it extends its expertise to clinical trial support through site management organization (SMO) services and broader clinical contract research organization (CRO) support. Its translational research division focuses on advancing novel medical solutions, such as the development of nasal drug delivery systems, nucleic acid-based adjuvants, and regenerative medicine therapies. Established in 1957, Shin Nippon Biomedical Laboratories, Ltd. maintains its headquarters in Tokyo, Japan.
Key statistics
Avg. volume
219.79K
Market cap
¥56.29B
P/E Ratio
10.48
Price-to-sales ratio
1.66
Enterprise value
¥79.54B
Free cash flow yield
0.00%
Debt-to-equity ratio
0.90
Return on equity
12.23%
ROIC
2.82%
Beta
-0.21
Dividend yield
3.70%
Last dividend
¥50.00
Financial overview
Revenue
¥32.52B
Earnings per share
¥109.69
Free cash flow
¥3.15B
Net profit margin
15.83%
Gross margin
49.55%
EBITDA
¥6.09B
Revenue growth
0.34%
Similar securities
This is not an investment recommendation
How to buy Shin Nippon Biomedical Laboratories from India
Indian residents can buy Shin Nippon Biomedical Laboratories shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.
Search for Shin Nippon Biomedical Laboratories and place an order
Find Shin Nippon Biomedical Laboratories by name or by its ticker, 2395, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Shin Nippon Biomedical Laboratories trades 5:30 am – 12:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Shin Nippon Biomedical Laboratories position in JPY and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Shin Nippon Biomedical Laboratories from India
Trading and taxes when buying Shin Nippon Biomedical Laboratories from India
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm JST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Shin Nippon Biomedical Laboratories’ current yield is 3.70%.Dividend tax explained
- Estate or inheritance tax
- May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Shin Nippon Biomedical Laboratories stock?
Yes. Shin Nippon Biomedical Laboratories (2395) has been listed on the Tokyo Stock Exchange since 2004, in the Medical - Diagnostics & Research industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Shin Nippon Biomedical Laboratories share cost in rupees?
One Shin Nippon Biomedical Laboratories share is ¥1,352.00 — about ₹823 at a JPY/INR rate of 0.6089 on 25 Sep 2026. Both the Shin Nippon Biomedical Laboratories price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Shin Nippon Biomedical Laboratories from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Shin Nippon Biomedical Laboratories?
The Tokyo Stock Exchange typically trades in units of 100 shares.
How are gains on Shin Nippon Biomedical Laboratories shares taxed in India?
Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Shin Nippon Biomedical Laboratories price. Paasa issues a capital-gains statement for your return.
Does Shin Nippon Biomedical Laboratories pay a dividend, and how is it taxed in India?
Yes. Shin Nippon Biomedical Laboratories pays a dividend and the current yield is 3.70%; the last declared dividend was ¥50.00 per share, about ₹30.44. Dividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Shin Nippon Biomedical Laboratories from India?
The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Shin Nippon Biomedical Laboratories shares held from India?
Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.
Do I have to declare Shin Nippon Biomedical Laboratories shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Shin Nippon Biomedical Laboratories holding, its cost and its closing value.
How do I sell Shin Nippon Biomedical Laboratories and bring the money back to India?
You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.